Literature DB >> 20967552

Oncomodulation by human cytomegalovirus: novel clinical findings open new roads.

Martin Michaelis1, Peter Baumgarten, Michel Mittelbronn, Pablo Hernáiz Driever, Hans Wilhelm Doerr, Jindrich Cinatl.   

Abstract

The question whether human cytomegalovirus may affect cancer diseases has been discussed (very controversially) for decades. There are convinced believers and strict opponents of the idea that HCMV might be able to play a role in the course of cancer diseases. In parallel, the number of published reports on the topic is growing. Recently published and presented (Ranganathan P, Clark P, Kuo JS, Salamat S, Kalejta RF. A Survey of Human Cytomegalovirus Genomic Loci Present in Glioblastoma Multiforme Tissue Samples. 35th Annual International Herpes Workshop, Salt Lake City, 2010) data on HCMV detection in glioblastoma tissues and colocalisation of HCMV proteins with cellular proteins known to be relevant for glioblastoma progression motivated us to recapitulate the current state of evidence.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20967552     DOI: 10.1007/s00430-010-0177-7

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  56 in total

Review 1.  Role of tumor cell immune escape mechanisms in cytomegalovirus-mediated oncomodulation.

Authors:  Jindrich Cinatl; Martin Scholz; Hans Wilhelm Doerr
Journal:  Med Res Rev       Date:  2005-03       Impact factor: 12.944

Review 2.  CD8 T-cell-based immunotherapy of cytomegalovirus infection: "proof of concept" provided by the murine model.

Authors:  Rafaela Holtappels; Verena Böhm; Jürgen Podlech; Matthias J Reddehase
Journal:  Med Microbiol Immunol       Date:  2008-03-15       Impact factor: 3.402

3.  HCMV-encoded chemokine receptor US28 mediates proliferative signaling through the IL-6-STAT3 axis.

Authors:  Erik Slinger; David Maussang; Andreas Schreiber; Marco Siderius; Afsar Rahbar; Alberto Fraile-Ramos; Sergio A Lira; Cecilia Söderberg-Nauclér; Martine J Smit
Journal:  Sci Signal       Date:  2010-08-03       Impact factor: 8.192

4.  Expression of DeltaNp73 is a molecular marker for adverse outcome in neuroblastoma patients.

Authors:  I Casciano; K Mazzocco; L Boni; G Pagnan; B Banelli; G Allemanni; M Ponzoni; G P Tonini; M Romani
Journal:  Cell Death Differ       Date:  2002-03       Impact factor: 15.828

Review 5.  The history of tumor virology.

Authors:  Ronald T Javier; Janet S Butel
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

6.  Epitope-specific in vivo protection against cytomegalovirus disease by CD8 T cells in the murine model of preemptive immunotherapy.

Authors:  Verena Böhm; Jürgen Podlech; Doris Thomas; Petra Deegen; Marcus-Folker Pahl-Seibert; Niels A W Lemmermann; Natascha K A Grzimek; Silke A Oehrlein-Karpi; Matthias J Reddehase; Rafaela Holtappels
Journal:  Med Microbiol Immunol       Date:  2008-03-14       Impact factor: 3.402

7.  Cytomegalovirus-induced gammadelta T cells associate with reduced cancer risk after kidney transplantation.

Authors:  Lionel Couzi; Yann Levaillant; Abdellah Jamai; Vincent Pitard; Regis Lassalle; Karin Martin; Isabelle Garrigue; Omar Hawchar; François Siberchicot; Nicholas Moore; Jean-François Moreau; Julie Dechanet-Merville; Pierre Merville
Journal:  J Am Soc Nephrol       Date:  2009-08-27       Impact factor: 10.121

8.  EBV-expressing AGS gastric carcinoma cell sublines present increased motility and invasiveness.

Authors:  Jareer Kassis; Akihiko Maeda; Norihiro Teramoto; Kenzo Takada; Chuanyue Wu; George Klein; Alan Wells
Journal:  Int J Cancer       Date:  2002-06-10       Impact factor: 7.396

9.  Epstein-Barr virus contributes to the malignant phenotype and to apoptosis resistance in Burkitt's lymphoma cell line Akata.

Authors:  J Komano; M Sugiura; K Takada
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

Review 10.  Murine cytomegalovirus regulation of NKG2D ligands.

Authors:  Tihana Lenac; Jurica Arapović; Luka Traven; Astrid Krmpotić; Stipan Jonjić
Journal:  Med Microbiol Immunol       Date:  2008-02-08       Impact factor: 3.402

View more
  24 in total

Review 1.  Immune modulation during latent herpesvirus infection.

Authors:  Douglas W White; R Suzanne Beard; Erik S Barton
Journal:  Immunol Rev       Date:  2012-01       Impact factor: 12.988

Review 2.  Recent publications in medical microbiology and immunology: a retrospective.

Authors:  H W Doerr; J Cinatl
Journal:  Med Microbiol Immunol       Date:  2011-10-29       Impact factor: 3.402

3.  Human cytomegalovirus infection in tumor cells of the nervous system is not detectable with standardized pathologico-virological diagnostics.

Authors:  Peter Baumgarten; Martin Michaelis; Florian Rothweiler; Tatjana Starzetz; Holger F Rabenau; Annemarie Berger; Lukas Jennewein; Anne K Braczynski; Kea Franz; Volker Seifert; Joachim P Steinbach; Regina Allwinn; Michel Mittelbronn; Jindrich Cinatl
Journal:  Neuro Oncol       Date:  2014-08-25       Impact factor: 12.300

4.  Consensus on the role of human cytomegalovirus in glioblastoma.

Authors:  Kristine Dziurzynski; Susan M Chang; Amy B Heimberger; Robert F Kalejta; Stuart R McGregor Dallas; Martine Smit; Liliana Soroceanu; Charles S Cobbs
Journal:  Neuro Oncol       Date:  2012-02-08       Impact factor: 12.300

5.  High-resolution profiling and analysis of viral and host small RNAs during human cytomegalovirus infection.

Authors:  Thomas J Stark; Justin D Arnold; Deborah H Spector; Gene W Yeo
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

Review 6.  Polymorphisms in DNA Repair Gene and Susceptibility to Glioma: A Systematic Review and Meta-Analysis Based on 33 Studies with 15 SNPs in 9 Genes.

Authors:  Kun Liu; Yugang Jiang
Journal:  Cell Mol Neurobiol       Date:  2016-04-07       Impact factor: 5.046

7.  Expression of insulin-like growth factor binding protein-2 (IGFBP-2) gene in negative and positive human cytomegalovirus glioblastoma multiforme tissues.

Authors:  Narges Ahani; Mohsen Karimi Arzenani; Reza Shirkoohi; Mohammad Rokouei; Majid Alipour Eskandani; Abbas Nikravesh
Journal:  Med Oncol       Date:  2013-12-19       Impact factor: 3.064

8.  The human cytomegalovirus lytic cycle is induced by 1,25-dihydroxyvitamin D3 in peripheral blood monocytes and in the THP-1 monocytic cell line.

Authors:  Shu-En Wu; William E Miller
Journal:  Virology       Date:  2015-05-15       Impact factor: 3.616

9.  Overexpression of enhancer of zeste human homolog 2 (EZH2) gene in human cytomegalovirus positive glioblastoma multiforme tissues.

Authors:  Narges Ahani; Reza Shirkoohi; Mohammad Rokouei; Majid Alipour Eskandani; Abbas Nikravesh
Journal:  Med Oncol       Date:  2014-10-08       Impact factor: 3.064

10.  Persistent HCMV infection of a glioblastoma cell line contributes to the development of resistance to temozolomide.

Authors:  Pankaj Singh; Donna M Neumann
Journal:  Virus Res       Date:  2019-11-29       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.